Hct Al

Hct Al is a prescription medication that contains the active ingredient hydrochlorothiazide. It is supplied in oral form, though the specific dosage strength is not disclosed. Hydrochlorothiazide belongs to the thiazide diuretic class and is used to manage fluid balance and blood pressure. The product is marketed in the European Union and requires a physician’s prescription.

Hydrochlorothiazide is indicated for several conditions that involve excess fluid retention or elevated blood pressure. It is commonly prescribed as part of a broader treatment plan for these disorders.

- Hypertension (high blood pressure) management - Edema associated with congestive heart failure - Edema due to liver cirrhosis - Edema related to renal disease - Combination therapy with other antihypertensive agents

Hydrochlorothiazide may cause a range of side effects, some of which are more frequently observed while others are less common but potentially serious.

Common: - Increased urination and possible dehydration - Low blood potassium (hypokalemia) - Elevated blood sugar levels - Dizziness or light‑headedness, especially when standing - Muscle cramps or weakness

Serious: - Severe electrolyte disturbances (e.g., hyponatremia) - Acute kidney injury - Allergic reactions such as rash or angioedema

Before starting hydrochlorothiazide, certain health considerations should be reviewed with a healthcare professional. These precautions help minimize risks and ensure safe use.

- Assess kidney function and electrolyte status regularly - Monitor blood pressure and adjust therapy as needed - Use cautiously in patients with diabetes or gout - Evaluate for potential sulfonamide allergy - Avoid abrupt discontinuation to prevent rebound hypertension - Discuss pregnancy or breastfeeding status with a clinician

Hydrochlorothiazide can affect or be affected by other medications, altering its efficacy or safety profile. Understanding these interactions supports optimal therapy.

Avoid: - Concurrent use with other potent diuretics - Combination with lithium, which may increase lithium toxicity - Co‑administration with non‑steroidal anti‑inflammatory drugs (NSAIDs) that can reduce diuretic effect

Use with caution: - ACE inhibitors or ARBs, which may enhance potassium loss - Antidiabetic agents, as blood glucose may rise - Corticosteroids, which can increase fluid retention risk